Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
3.930
+0.415 (11.81%)
Jun 23, 2026, 2:14 PM EDT - Market open

SHPH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
8.437.864.082.381.30.72
Research & Development
-4.053.623.521.051.02
Total Operating Expenses
8.4311.927.75.892.341.74
Operating Income
-8.43-11.92-7.7-5.89-2.34-1.74
Interest Income
000.040.08--
Interest Expense
-0.07-0.07-1.21-2.49-0.48-0.05
Other Non-Operating Income (Expense)
0.090.26-0.281.71-2.170.64
Total Non-Operating Income (Expense)
0.020.2-1.45-0.7-2.650.59
Pretax Income
-8.42-11.72-9.14-6.59-5-1.15
Net Income
-10.82-11.72-9.14-6.59-5-1.15
Net Income Attributable to Preferred Dividends
----1.750.1
Net Income to Common
-10.82-11.72-9.14-6.59-6.75-1.26
Shares Outstanding (Basic)
000000
Shares Outstanding (Diluted)
000000
Shares Change (YoY)
1329.43%1318.21%54.71%60.51%-0.11%
EPS (Basic)
-47.10-71.60-796.50-882.50-1260.00-240.00
EPS (Diluted)
-47.10-71.60-826.00-882.50-1260.00-240.00
Free Cash Flow
-9.37-9.48-7.33-5.6-2.67-0.3
Free Cash Flow Per Share
-33.59-57.89-634.43-750.18-573.31-64.58
EBITDA
-7.51-11.63-7.69-5.89-2.34-1.68
EBIT
-8.43-11.92-7.7-5.89-2.34-1.74
SEC Filings: 10-K · 10-Q